| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 10/06/1999 | EP0946138A2 Use of a potentilla erecta extract in the cosmetic and pharmaceutical field |
| 10/06/1999 | EP0866693A4 Topically applied, structural cellulite treatments |
| 10/06/1999 | EP0584068B1 Method and composition for ameliorating the adverse effects of aging |
| 10/06/1999 | CN1230420A Psoriasis treating Chinese medicine preparation and its preparing process |
| 10/06/1999 | CN1230415A Combined Chinese and Western medicine for treating nevus and its preparation |
| 10/05/1999 | US5962707 19-nor-vitamin D3 compounds with calcemic activity |
| 10/05/1999 | US5962698 Plasminogen activator inhibitor |
| 10/05/1999 | US5962672 Antisense modulation of RhoB expression |
| 10/05/1999 | US5962663 Producing biopolymer with high molecular weight and low viscosity by repeatedly contacting fresh crustacean shells with aqueous mineral acid and alkali metal hydroxide solutions |
| 10/05/1999 | US5962529 Metalloproteinase inhibitors |
| 10/05/1999 | US5962524 For skins |
| 10/05/1999 | US5962482 Method of reducing cellulite in mamalian skin |
| 10/05/1999 | US5962479 Psychological and nervous sytem disorders |
| 10/05/1999 | US5962441 Anti-aging lotion |
| 10/05/1999 | US5962431 Method of treating papillomavirus using 2',5'-oligoadenylate |
| 10/05/1999 | US5962427 Targeting, transferring dna into mammalian repair cells |
| 10/05/1999 | US5962417 Reducing activation of tyrosinase |
| 10/05/1999 | US5962300 Polynucleotide which encodes a polypeptide tumor suppressor; for diagnosis, prevention, and treatment of cancer, eczema, psoriasis, psoriasis, scleroderma, dermatitis, skin atrophy, and other skin disorders; anticarcinogenic agents |
| 10/05/1999 | US5962010 Methods and compositions for treating dermatoses |
| 10/05/1999 | US5961993 Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the treatment of acne |
| 10/05/1999 | US5961990 Cosmetic particulate gel delivery system and method of preparing complex gel particles |
| 10/05/1999 | US5961988 Barium or strontium hexaferrite single crystals, samarium-cobalt particles and neodymium-iron-boron particles; aggregates consist of fluorocarbons and natural phospholipids with a phosphatidylcholine content of 30 to 99 wt %. |
| 10/05/1999 | US5961981 Biologically-active compositions extracted from dictyotales plant family |
| 10/05/1999 | CA2195924C 3-aza and 3-oxa-piperidone tachykinin antagonists |
| 09/30/1999 | WO1999049858A1 Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis |
| 09/30/1999 | WO1999049065A1 Antisense modulation of human mdm2 expression |
| 09/30/1999 | WO1999049039A2 GFRα3 AND ITS USES |
| 09/30/1999 | WO1999049027A1 Methods for prevention and treatment of cancer |
| 09/30/1999 | WO1999048925A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 09/30/1999 | WO1999048868A2 Heterocyclic classes of compounds for the modulating tyrosine protein kinase |
| 09/30/1999 | WO1999048537A1 Use of scatter factor to enhance angiogenesis |
| 09/30/1999 | WO1999048536A2 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo |
| 09/30/1999 | WO1999048521A1 Sciellin and uses thereof |
| 09/30/1999 | WO1999048512A1 Use of at least one protein extract of the moringa genus plant seeds and corresponding cosmetic and/or pharmacological composition |
| 09/30/1999 | WO1999048495A1 Benzoates derivatives for inhibiting angiogenesis |
| 09/30/1999 | WO1999048471A1 Polyalkoxy copolymers as lipase inhibitors and their compositions |
| 09/30/1999 | WO1999038532A3 Methods for the prevention and treatment of fibrosis and sclerosis |
| 09/30/1999 | WO1999038495A3 Controlled release delivery of peptide or protein |
| 09/30/1999 | WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 09/30/1999 | CA2326053A1 Use of scatter factor to enhance angiogenesis |
| 09/30/1999 | CA2325935A1 Heterocyclic families of compounds for the modulation of tyrosine protein kinase |
| 09/30/1999 | CA2324347A1 Benzoates derivatives for inhibiting angiogenesis |
| 09/30/1999 | CA2324340A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 09/30/1999 | CA2323782A1 Methods for prevention and treatment of cancer |
| 09/30/1999 | CA2322773A1 Antisense modulation of human mdm2 expression |
| 09/30/1999 | CA2291066A1 Local delivery of long lasting therapeutic agents |
| 09/29/1999 | EP0945464A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 09/29/1999 | EP0945130A2 Use of alpha-omega substituted oxyalkylated silicones in cosmetics and pharmaceuticals |
| 09/29/1999 | EP0944647A1 Submucosa extracts |
| 09/29/1999 | EP0944645A1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME |
| 09/29/1999 | EP0944630A1 Xanthines and their therapeutic use |
| 09/29/1999 | EP0944616A1 Bicyclic aryl carboxamides and their therapeutic use |
| 09/29/1999 | EP0944599A1 Triarylethanes useful as pde iv inhibitors |
| 09/29/1999 | EP0944592A1 Vitamin d3 derivatives |
| 09/29/1999 | EP0944310A1 Stabilized ascorbyl compositions |
| 09/29/1999 | CN1230196A Modified aminoacids, pharmaceuticals containing these compounds and method for their prodn. |
| 09/29/1999 | CN1230195A Treatment of immune disorders |
| 09/29/1999 | CN1230187A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/29/1999 | CN1230185A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/29/1999 | CN1230174A Benzamidine derivatives and use thereof as medicaments with LTB4-antagonistic effect |
| 09/29/1999 | CN1229669A Extract for treating sore and carbuncle |
| 09/29/1999 | CN1229666A Chilblain paste |
| 09/29/1999 | CN1229665A Hair growth agent |
| 09/29/1999 | CN1229657A Haisong injury paste |
| 09/29/1999 | CN1229648A Biological cream and its prepn. method |
| 09/29/1999 | CN1229642A Deodorization powder for foot |
| 09/29/1999 | CN1229640A Oxidation dyeing process and oxidation, dye composition for keratin fibres which comprises cationic amphiphilic polymer |
| 09/29/1999 | CN1229637A Transparent antidandruff shampoos |
| 09/28/1999 | US5959127 Acylating sphingosine or sphinganine, hydrolyzing to deblock |
| 09/28/1999 | US5958976 Composition and method for reducing stinging in skin |
| 09/28/1999 | US5958975 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 09/28/1999 | US5958956 Aromatic carboxylic acid esters |
| 09/28/1999 | US5958954 2,2-dialkyl-4-aryl-substituted benzopyran and benzothiopyran derivatives |
| 09/28/1999 | US5958953 Substituted indazole derivatives |
| 09/28/1999 | US5958943 A!-anellated pyrrole derivatives and their use in pharmacology |
| 09/28/1999 | US5958905 Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin |
| 09/28/1999 | US5958891 Administering vector comprising gene encoding dust mite allergen by intramuscular injection to prevent airway hyperreactivity or airway inflammation |
| 09/28/1999 | US5958880 Feline Fc epsilon receptor alpha chain proteins and therapeutic uses thereof |
| 09/28/1999 | US5958731 Cell junction PDZ protein |
| 09/28/1999 | US5958437 Pigment stabilizer comprising mixture of glycerin, butylene glycol, bearberry extract, mitracarpus extract, magnesium ascorbyl phosphate, tricholoma matsutake extract |
| 09/28/1999 | US5958432 Cosmetic/pharmaceutical compositions comprising β-adrenergic agonists/substance P antagonists |
| 09/28/1999 | US5958421 Cosmetic or pharmaceutical composition containing an andiroba extract |
| 09/28/1999 | US5958420 Treatment of burns, cuts, and abrasions of the skin |
| 09/28/1999 | US5958406 Acne treatment with multifunctional enzyme |
| 09/28/1999 | US5958405 Human protein tyrosine kinase |
| 09/28/1999 | US5958395 Cosmetic preparation containing Ilex resin, method of obtaining Ilex and Ilex resin obtained thereby |
| 09/28/1999 | US5958377 Methods of delivering gases to gas-depleted environments |
| 09/28/1999 | CA2148417C Serine derivatives; process for preparing them and their use in cosmetic and dermatological compositions |
| 09/28/1999 | CA1340773C Anti-neoplastic, anti-viral or anti-retoviral sperime derivative |
| 09/26/1999 | CA2264323A1 W/h emulsion, composition comprising such an emulsion and its cosmetic, pharmaceutical or hygienic uses |
| 09/24/1999 | CA2264249A1 Heat-activated skin patch and use of same |
| 09/23/1999 | WO1999047677A2 Polypeptides homologous to vegf and bmp1 |
| 09/23/1999 | WO1999047670A1 Mammalian sodium channel proteins |
| 09/23/1999 | WO1999047563A2 Ribonucleotide polypeptides containing metal |
| 09/23/1999 | WO1999047561A1 Ribonucleotide polypeptides containing metal |
| 09/23/1999 | WO1999047550A1 Novel matrix metalloproteinase inhibitors and down-regulators |
| 09/23/1999 | WO1999047547A1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 09/23/1999 | WO1999047545A2 Inhibitors of caspases |
| 09/23/1999 | WO1999047538A1 Cytokine receptor common gamma chain like |
| 09/23/1999 | WO1999047524A1 Novel heterocyclic compounds |